Paragon 28 (NYSE:FNA) posted its earnings results on Sunday. The company reported ($0.12) EPS for the quarter, missing the consensus estimate of ($0.08) by ($0.04), MarketWatch Earnings reports.
Paragon 28 stock opened at $20.68 on Wednesday. Paragon 28 has a 1-year low of $17.25 and a 1-year high of $25.41.
FNA has been the subject of several recent research reports. JMP Securities reiterated a “buy” rating and issued a $29.00 price target on shares of Paragon 28 in a research note on Tuesday. Needham & Company LLC began coverage on Paragon 28 in a research note on Tuesday, November 9th. They issued a “buy” rating and a $31.00 price target for the company. Piper Sandler started coverage on Paragon 28 in a report on Tuesday, November 9th. They issued an “overweight” rating and a $30.00 price objective for the company. Finally, Canaccord Genuity started coverage on Paragon 28 in a report on Tuesday, November 9th. They set a “buy” rating and a $28.00 price target for the company.
Paragon 28 Inc is a medical device company exclusively focused on the foot and ankle orthopedic market. Paragon 28 Inc is based in ENGLEWOOD, Colo.
Featured Article: How can investors invest in the Euro STOXX 50 Index?
Receive News & Ratings for Paragon 28 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Paragon 28 and related companies with MarketBeat.com's FREE daily email newsletter.